14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
PSAI vs USPH: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, US Physical Therapy Inc (USPH) is the stronger overall head-to-head candidate over PSAI (PSAI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PSAI carries a Unified Composite Score of 54.8/100 (HOLD) at $29.30 (N/M Forward P/E, N/A operating margin), whereas USPH carries 31.8/100 (SELL) at $99.55 (29.6x Forward P/E, 10.2% operating margin).
Composite vs. Pillar Nuance: While PSAI currently prints a higher short-term Unified Composite Score (54.8/100 HOLD vs. USPH 31.8/100 SELL), USPH captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (10.2% vs. N/A operating margin) and revenue trajectory (+13.1% vs. N/A YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PSAI vs USPH. Trailing 12-month operating profitability (PSAI N/A vs USPH 10.2%) and valuation multiples (PSAI N/M vs USPH 29.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Care Facilities value chain with $1.5B market capitalization and 10.2% operating margin.
OpEx & R&D Reinvestment11.4% of Rev ($95M)
90D Engineering Disclosures0 Published
Investor FAQ PSAI vs USPH Key Questions & Quantitative Answers
As of Nov 16, 2026, US Physical Therapy Inc (USPH) is the stronger overall head-to-head candidate over PSAI (PSAI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PSAI carries a Unified Composite Score of 54.8/100 (HOLD) at $29.30 (N/M Forward P/E, N/A operating margin), whereas USPH carries 31.8/100 (SELL) at $99.55 (29.6x Forward P/E, 10.2% operating margin). Composite vs. Pillar Nuance: While PSAI currently prints a higher short-term Unified Composite Score (54.8/100 HOLD vs. USPH 31.8/100 SELL), USPH captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (10.2% vs. N/A operating margin) and revenue trajectory (+13.1% vs. N/A YoY).
USPH leads the Growth & Scale pillar: PSAI posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with USPH at +13.1% YoY revenue growth and -56.5% YoY earnings growth on $830M TTM revenue (21.6% gross margin, 10.2% operating margin). On trailing 12-month operating scale, PSAI generates N/A in USD-normalized revenue versus $830M for USPH. In operating R&D and SG&A reinvestment, PSAI deploys N/A (0 90-day corporate R&D disclosures) versus 11.4% of Rev ($95M) (0 disclosures) for USPH.
USPH screens cheaper on headline valuation multiples. PSAI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas USPH trades at 29.6x Forward P/E, 32.9x Trailing P/E, 3.29x PEG, and 1.8x EV/Revenue (12.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PSAI (N/A ROE) versus USPH (6.3% ROE) capital efficiency.
In options market volatility and institutional positioning, PSAI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.80β · 13% Vol realized risk). By comparison, USPH carries 35.3% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 42% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.